- Open call
- Open access · CC BY 4.0
Call for Papers
The In-vitro In-vivo In-silico Journal welcomes submissions throughout the year from researchers, clinicians and multidisciplinary teams working on the discovery, development and delivery of new drugs. Regular submissions are accepted throughout the year.
Research the journal welcomes
IIIJ publishes research that uses in-vitro, in-vivo and in-silico approaches, alone or combined, with drug discovery and development as its core. The topics listed illustrate the range of work the journal considers, including but not limited to:
- Pharmacology and mechanisms of drug action
- Pharmacokinetics and pharmacodynamics
- Toxicology and safety assessment
- Structure–activity relationships
- Drug delivery and formulation
- Medicinal chemistry
- Cheminformatics and computational drug design
- Pharmacogenomics
- Food chemistry and bioactive compounds
- Cost and benefit evaluation of new drugs
Article types
A narrative literature review is submitted as a Review, and a case series as a Case Report.
- Original Research
- Review
- Systematic Review and Meta-Analysis
- Methods
- Short Communication
- Data Note
- Case Report
- Commentary
- Letter
There are no fixed length limits for any article type; manuscripts should be concise and proportionate to their content.
How to submit
Please prepare the manuscript according to the Instructions for Authors, then submit it through one of the routes below.
Authors must use only one submission route for the same manuscript.
Review, publication and fees
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review.
Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.
Accepted articles are published open access under the Creative Commons Attribution 4.0 license (CC BY 4.0); authors retain copyright.
USD 1,200, payable only after acceptance; withdrawal after submission is subject to the journal’s withdrawal policy. Fee-relief inquiries are considered case by case; contact the editorial office before or at submission.
Contact the editorial office
Questions about the fit of a manuscript or about submission requirements can be sent to the editorial office at info@openaccesspub.org.